1. Baumel IP, Gallagher BB, Mattson RH (1972) Phenylethylmalonamide (PEMA). An important metabolite of primidone. Arch Neurol 27: 34?41
2. Booker HE, Hosokowa K, Burdette RD, Darcey B (1970) A clinical study of serum primidone levels. Epilepsia 11: 395?402
3. Boréus LO, Jalling B, Wallin A (1978) Plasma concentrations of phenobarbital in mother and child after combined prenatal and postnatal administration for prophylaxis of hyperbilirubinemia. J Pediatr 93: 695?698
4. Bossi L, Assael BM, Avanzini G, Battino D, Caccamo ML, Canger R, Como ML, Pifarotti G, Giambattista de M, Franceschetti S, Marini A, Pardi G, Porro MG, Rovei V, Sanjuan M, Soffientini ME, Spina S, Spreafico R (1980) Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newborns. In: Johannessen SI, Morselli PL, Pippenger CE, Richens A, Schmidt D, Meinardi H (eds) Antiepileptic therapy. Advances in drug monitoring. Raven Press, New York, pp 9?18
5. Brodie BB, Axelrod J (1950) The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther 99: 171?184